skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Practical issues in medication compliance in hypertensive patients

Review

(1519) Views  (317) Full article downloads

Authors: Krzesinski J, Leeman M

Published Date June 2011 Volume 2011:2 Pages 63 - 70
DOI: http://dx.doi.org/10.2147/RRCC.S12671

Jean-Marie Krzesinski1, Marc Leeman2
1Nephrology Transplantation Department, Domaine Universitaire, Liège, Belgium; 2Department of Internal Medicine and Hypertension Clinic, Erasme University Hospital, Brussels, Belgium

Abstract: Unsatisfactory compliance in the treatment of high blood pressure is frequently due to sequential barriers, such as insufficient patient education about the illness and low motivation to receive any treatment, existence of a large gap between physicians' perceptions of the problem and clinical reality, complexity of the treatment potentially generating adverse effects, and a health care environment with few public education campaigns and incentives for better coordinated supportive care. In order to improve drug compliance, establishment of personalized plans adapted to each patient is required. First, a good doctor–patient relationship is mandatory, with regular education of the patient about hypertension and its risks, discussion about adverse drug effects, and the complexity and cost of treatment. Second, to have any chance of success, the provider should offer convenient appointments and tailor the treatment regimen to the patient's lifestyle and needs, with written instructions. Third, there is a need to promote active patient collaboration with treatment. An innovative combination of home self-measurement of blood pressure, use of new technology options, eg, texting or telemedicine, and creation of a multidisciplinary working team can offer new, effective opportunities. This approach could reduce cardiovascular complications by improving the control of high blood pressure, and thereby the overall costs of hypertension to the health care system.

Keywords: arterial hypertension, therapeutic adherence, drug compliance, persistence




 

Other articles by Professor Jean-Marie Krzesinski



Readers of this article also read:

Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes
High-density lipoproteins: a novel therapeutic target for cardiovascular disease
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Psychosocial dimensions of SLE: implications for the health care team
Clinical experience with apixaban in atrial fibrillation: implications of AVERROES
Critical evaluation of ivabradine for the management of chronic stable angina
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Emerging options to prevent stroke in atrial fibrillation patients
Sudden death in eating disorders
Examining human rights and mental health among women in drug abuse treatment centers in Afghanistan